SlideShare une entreprise Scribd logo
1  sur  70
IMMUNOPHARMACOLOGY Ma. Janetth B. Serrano, M.D., DPBA
IMMUNOPHARMACOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGY 0psonized bacteria Macrophage APC T lymphocyte IL-2 IL-2 IFN-  Activated Macrophage Activated NK  cells Activated Cytotoxic T cell CELL-MEDIATED IMMUNITY B lymphocyte IL-4,IL-5 TH 1 TH 2 Memory B Cells ,[object Object],[object Object],[object Object],HUMORAL  IMMUNITY IFN-  TNF-  IFN- 
[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Immunosuppressants IMMUNOPHARMACOLOGY
Corticosteroids IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Corticosteroids IMMUNOPHARMACOLOGY
Cyclosporin IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Cyclosporin IMMUNOPHARMACOLOGY
Tacrolimus IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Tacrolimus IMMUNOPHARMACOLOGY
Sirolimus (rapamycin) IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Sirolimus (rapamycin) IMMUNOPHARMACOLOGY
Interferons IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Interferons IMMUNOPHARMACOLOGY
TNF- α binding drugs IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
TNF- α binding drugs IMMUNOPHARMACOLOGY
Mycophenolate  Mofetil IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Mycophenolate  Mofetil IMMUNOPHARMACOLOGY
15-Deoxyspergualin IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
15-Deoxyspergualin IMMUNOPHARMACOLOGY
Thalidomide IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Thalidomide IMMUNOPHARMACOLOGY
Glatiramer IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Glatiramer IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY CYTOTOXIC Agents:
Azathioprine IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Azathioprine IMMUNOPHARMACOLOGY
Leflunomide IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Leflunomide IMMUNOPHARMACOLOGY
Cyclophosphamide IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Cyclophosphamide IMMUNOPHARMACOLOGY
Antibodies as Immunosuppressive Agents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY MONOCLONAL   ANTIBODIES :
Muromonab-CD3 IMMUNOPHARMACOLOGY
[object Object],[object Object],IMMUNOPHARMACOLOGY Muromonab-CD3
Muromonab-CD3 IMMUNOPHARMACOLOGY
[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY MONOCLONAL   ANTIBODIES :
[object Object],[object Object],[object Object],IMMUNOPHARMACOLOGY
Interferon-alpha
IMMUNOMODULATORS ,[object Object],-  hairy cell leukemia - chronic myelogenous leukemia - malignant melanoma - Kaposi’s sarcoma - anticancer    renal cell CA, carcinoid syndrome, T cell leukemia
Interferon-alpha
IMMUNOMODULATORS ,[object Object],GM-CSF Interferons & IL-2 TNF-alpha Interleukin-2 Interferon-gamma Interferon-beta
IMMUNOMODULATORS ,[object Object],Melanoma and Prostate cancer (+) effects in response to Hep B vaccine Malignant melanoma Soft tissue sarcoma of extremities Metastatic renal cell CA Malignant melanoma Chronic granulomatous disease Relapsing type multiple sclerosis
IMMUNOMODULATORS ,[object Object],GM-CSF Interferons & IL-2 TNF-alpha Interleukin-2 Interferon-gamma Interferon-beta
LEVAMISOLE IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY - antiparasitic agent - potentiate action of fluorouracil in adjuvant therapy of  Dukes class C colorectal CA - other uses: > hodgkin’s lymphoma > RA
LEVAMISOLE IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
BCG (Bacille-Camille-Guarin) IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY - immunization against tuberculosis - Adjuvant in intravesical therapy for SF bladder CA
BCG (Bacille-Camille-Guarin) IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGY IMMUNOMODULATORS IMMUNOPHARMACOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Immunopharmacology
ImmunopharmacologyImmunopharmacology
ImmunopharmacologyNaser Tadvi
 
Immunomodulators
ImmunomodulatorsImmunomodulators
ImmunomodulatorsRahul B S
 
immunostimulants
immunostimulantsimmunostimulants
immunostimulantsacademic
 
immunostimulants and immunosupprasants.pptx
immunostimulants and immunosupprasants.pptximmunostimulants and immunosupprasants.pptx
immunostimulants and immunosupprasants.pptxSaurabh Gupta
 
Immunosuppressants Pharmacology
Immunosuppressants PharmacologyImmunosuppressants Pharmacology
Immunosuppressants PharmacologyBAVAMH
 
Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Manohar Kuppala
 
Anticancer drugs: Classification , general toxicity and Alkylating agents.
Anticancer drugs: Classification , general toxicity and Alkylating agents.Anticancer drugs: Classification , general toxicity and Alkylating agents.
Anticancer drugs: Classification , general toxicity and Alkylating agents.Ameena Kadar
 
Immunosuppressants final drug ppt
Immunosuppressants  final drug pptImmunosuppressants  final drug ppt
Immunosuppressants final drug pptGAMANDEEP
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
ImmunopharmacologyDrx Burade
 
Endocrine pharmacology
Endocrine pharmacologyEndocrine pharmacology
Endocrine pharmacologyPavana K A
 
Pharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdPharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdLalitaShahgond
 

Tendances (20)

immuno stimulants
immuno stimulants immuno stimulants
immuno stimulants
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Immunostimulants
ImmunostimulantsImmunostimulants
Immunostimulants
 
Prokinetics 1
Prokinetics 1Prokinetics 1
Prokinetics 1
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
Prokinetics
ProkineticsProkinetics
Prokinetics
 
Immunomodulators(VK)
Immunomodulators(VK)Immunomodulators(VK)
Immunomodulators(VK)
 
Anticancer drugs - drdhriti
Anticancer drugs - drdhritiAnticancer drugs - drdhriti
Anticancer drugs - drdhriti
 
immunostimulants
immunostimulantsimmunostimulants
immunostimulants
 
immunostimulants and immunosupprasants.pptx
immunostimulants and immunosupprasants.pptximmunostimulants and immunosupprasants.pptx
immunostimulants and immunosupprasants.pptx
 
Immunosuppressants Pharmacology
Immunosuppressants PharmacologyImmunosuppressants Pharmacology
Immunosuppressants Pharmacology
 
Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity Geno toxicity, carcinogenicity and teratogenicity
Geno toxicity, carcinogenicity and teratogenicity
 
Anticancer drugs: Classification , general toxicity and Alkylating agents.
Anticancer drugs: Classification , general toxicity and Alkylating agents.Anticancer drugs: Classification , general toxicity and Alkylating agents.
Anticancer drugs: Classification , general toxicity and Alkylating agents.
 
Immunosuppressant drugs
Immunosuppressant drugsImmunosuppressant drugs
Immunosuppressant drugs
 
IMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGYIMMUNOPHARMACOLOGY
IMMUNOPHARMACOLOGY
 
Immunosuppressants final drug ppt
Immunosuppressants  final drug pptImmunosuppressants  final drug ppt
Immunosuppressants final drug ppt
 
Immunostimulants
ImmunostimulantsImmunostimulants
Immunostimulants
 
Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Endocrine pharmacology
Endocrine pharmacologyEndocrine pharmacology
Endocrine pharmacology
 
Pharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copdPharmacotherapy of asthma and copd
Pharmacotherapy of asthma and copd
 

Similaire à Immunopharmacology

Immunity, immunosuppresant’s
Immunity, immunosuppresant’sImmunity, immunosuppresant’s
Immunity, immunosuppresant’sN K
 
immunosuppressants.pptx
immunosuppressants.pptximmunosuppressants.pptx
immunosuppressants.pptxsumiaru
 
PH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptxPH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptxDr-Mani Bharti
 
Immunotherapy dr. ihsan alsaimary
Immunotherapy dr. ihsan alsaimaryImmunotherapy dr. ihsan alsaimary
Immunotherapy dr. ihsan alsaimarydr.Ihsan alsaimary
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. PosadaMedicineAndHealthCancer
 
Biological response modifiers
Biological response modifiersBiological response modifiers
Biological response modifiersjireankita
 
Management of rheumatoid arthritis
Management of rheumatoid arthritisManagement of rheumatoid arthritis
Management of rheumatoid arthritisZafar Masood
 
Immunopharmacology 2003
Immunopharmacology 2003Immunopharmacology 2003
Immunopharmacology 2003Sanjita Das
 
IMMUNOSUPPRESSANT DRUGS.ppt
IMMUNOSUPPRESSANT DRUGS.pptIMMUNOSUPPRESSANT DRUGS.ppt
IMMUNOSUPPRESSANT DRUGS.pptZORAIZ HAIDER
 
Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01kamal_1981
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapyNeha Patel
 
Cytokines as drug targets.pptx
Cytokines as drug targets.pptxCytokines as drug targets.pptx
Cytokines as drug targets.pptxSeema Bansal
 

Similaire à Immunopharmacology (20)

Immunopharmacology
ImmunopharmacologyImmunopharmacology
Immunopharmacology
 
Immunity, immunosuppresant’s
Immunity, immunosuppresant’sImmunity, immunosuppresant’s
Immunity, immunosuppresant’s
 
Immunomodulators
ImmunomodulatorsImmunomodulators
Immunomodulators
 
immunosuppressants.pptx
immunosuppressants.pptximmunosuppressants.pptx
immunosuppressants.pptx
 
Immunosuppressants
ImmunosuppressantsImmunosuppressants
Immunosuppressants
 
PH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptxPH 1.50 immunomodulators.pptx
PH 1.50 immunomodulators.pptx
 
Immunotherapy dr. ihsan alsaimary
Immunotherapy dr. ihsan alsaimaryImmunotherapy dr. ihsan alsaimary
Immunotherapy dr. ihsan alsaimary
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. Posada
 
Biological response modifiers
Biological response modifiersBiological response modifiers
Biological response modifiers
 
Seminar sunil
Seminar sunilSeminar sunil
Seminar sunil
 
Management of rheumatoid arthritis
Management of rheumatoid arthritisManagement of rheumatoid arthritis
Management of rheumatoid arthritis
 
IMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGSIMMUNOSUPPRESSANT DRUGS
IMMUNOSUPPRESSANT DRUGS
 
Immunopharmacology 2003
Immunopharmacology 2003Immunopharmacology 2003
Immunopharmacology 2003
 
Biologics
BiologicsBiologics
Biologics
 
seminar on MAS
seminar on MASseminar on MAS
seminar on MAS
 
IMMUNOSUPPRESSANT DRUGS.ppt
IMMUNOSUPPRESSANT DRUGS.pptIMMUNOSUPPRESSANT DRUGS.ppt
IMMUNOSUPPRESSANT DRUGS.ppt
 
Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology  Monoclonal Antibodies and their role in Pharmacology
Monoclonal Antibodies and their role in Pharmacology
 
Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01Mabjeevan 141027001544-conversion-gate01
Mabjeevan 141027001544-conversion-gate01
 
Cancer immunotherapy
Cancer immunotherapyCancer immunotherapy
Cancer immunotherapy
 
Cytokines as drug targets.pptx
Cytokines as drug targets.pptxCytokines as drug targets.pptx
Cytokines as drug targets.pptx
 

Plus de MD Specialclass

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...MD Specialclass
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionMD Specialclass
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headachesMD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL MD Specialclass
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinomaMD Specialclass
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disordersMD Specialclass
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitisMD Specialclass
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosisMD Specialclass
 

Plus de MD Specialclass (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
Hema intro anemia
Hema intro anemiaHema intro anemia
Hema intro anemia
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 

Dernier

Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Orbitshub
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsNanddeep Nachan
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Angeliki Cooney
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAndrey Devyatkin
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfOrbitshub
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingEdi Saputra
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontologyjohnbeverley2021
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodJuan lago vázquez
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesrafiqahmad00786416
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxRemote DBA Services
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century educationjfdjdjcjdnsjd
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Bhuvaneswari Subramani
 

Dernier (20)

Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
WSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering DevelopersWSO2's API Vision: Unifying Control, Empowering Developers
WSO2's API Vision: Unifying Control, Empowering Developers
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
AWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of TerraformAWS Community Day CPH - Three problems of Terraform
AWS Community Day CPH - Three problems of Terraform
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Six Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal OntologySix Myths about Ontologies: The Basics of Formal Ontology
Six Myths about Ontologies: The Basics of Formal Ontology
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin WoodPolkadot JAM Slides - Token2049 - By Dr. Gavin Wood
Polkadot JAM Slides - Token2049 - By Dr. Gavin Wood
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
Vector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptxVector Search -An Introduction in Oracle Database 23ai.pptx
Vector Search -An Introduction in Oracle Database 23ai.pptx
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​Elevate Developer Efficiency & build GenAI Application with Amazon Q​
Elevate Developer Efficiency & build GenAI Application with Amazon Q​
 

Immunopharmacology